Patents by Inventor Jeffrey H. Burbank
Jeffrey H. Burbank has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 12112849Abstract: A medical treatment device is configured to be used during a treatment session at a first location and includes a medical treatment component configured to perform at least one of hemodialysis, hemofiltration, and peritoneal dialysis on a patient during the treatment session at the first location. The device also includes a monitoring system configured to receive data from one or more sensors connected to the monitoring system, and to confirm a presence of an authorized helper at the first location. A user interface permits an operator to control functions of the medical treatment component and the monitoring system is configured to perform the presence confirmation automatically and at the predefined time intervals during the treatment session. The monitoring system is also configured to generate an alarm and to cause the medical treatment component to go into a failsafe operational mode.Type: GrantFiled: August 5, 2022Date of Patent: October 8, 2024Assignee: NxStage Medical, Inc.Inventors: Jeffrey H. Burbank, Dennis M. Treu, James M. Brugger
-
Publication number: 20240277909Abstract: A medicament preparation system includes a water purification module and a medicament proportioning module that is interoperable with a replaceable fluid circuit. The fluid circuit includes a purified water inlet, a product medicament outlet, and a plurality of pumping tube segments. At least a first concentrate container is connected by at least a portion of the fluid circuit to the product medicament output and a first concentration measurement sensor station is positioned in a flow path. A controller is programmed to calculate iteratively a concentration of a first concentrate from the first concentrate container and the purified water from a signal generated by the first concentration measurement sensor station and to regulate one or both of a first pumping actuator engaged with the first pumping tube segment and a second pumping actuator engaged with the second pumping tube segment, responsively to the concentration of the first concentrate and water.Type: ApplicationFiled: April 29, 2024Publication date: August 22, 2024Applicant: NxStage Medical, Inc.Inventors: Goetz FRIEDERICHS, William K. WEIGEL, Dennis M. TREU, Jeffrey H. BURBANK, James M. BRUGGER, Keith David J. WHEELER, Scott W. NEWELL
-
Publication number: 20240277910Abstract: A medical treatment system includes a disposable fluid circuit that includes a water inlet and a batch container arranged to hold a mixture, the mixture including water that is received from the water inlet and at least one concentrate. The fluid circuit also includes a drain line for draining fluid from the disposable fluid circuit, and a manifold with a plurality of fluid lines, the manifold connecting the water inlet, the batch container, a source of the at least one concentrate, and the drain line. A source of purified water supplies the purified water to the water inlet and a sensor detects a property of fluid in the disposable fluid circuit. A controller controls flowing of a first fluid followed by displacement by a second fluid causing the first fluid to flow to the sensor.Type: ApplicationFiled: April 10, 2024Publication date: August 22, 2024Applicant: NxStage Medical, Inc.Inventors: Jeffrey H. BURBANK, James M. BRUGGER, Dennis M. TREU, Mark T. WYETH
-
Patent number: 12048791Abstract: Peritoneal dialysis admixing and/or treatment devices, methods, and systems are disclosed. The systems, methods, and devices provide high-level guarantees of sterility and employs relatively inexpensive disposable components to provide pumping. Disclosed systems, methods, and devices and features thereof are adapted for point of use generation of medicament. In particular admixing systems that employ independently-replaceable long term concentrate are disclosed. Features are directed to assurance of sterility and accurate admixing of water and concentrate to generate ready-to-use medicaments and other benefits.Type: GrantFiled: June 24, 2018Date of Patent: July 30, 2024Assignee: NxStage Medical, Inc.Inventors: Mark T. Wyeth, Gregory Yantz, James Ian Johnson, James M. Brugger, Dennis M. Treu, Dritan Kurshumi, Jeffrey H. Burbank, William J. Schnell, Robert Paul McCarty
-
Patent number: 11986582Abstract: A medicament preparation system includes a water purification module and a medicament proportioning module that is interoperable with a replaceable fluid circuit. The fluid circuit includes a purified water inlet, a product medicament outlet, and a plurality of pumping tube segments. At least a first concentrate container is connected by at least a portion of the fluid circuit to the product medicament output and a first concentration measurement sensor station is positioned in a flow path. A controller is programmed to calculate iteratively a concentration of a first concentrate from the first concentrate container and the purified water from a signal generated by the first concentration measurement sensor station and to regulate one or both of a first pumping actuator engaged with the first pumping tube segment and a second pumping actuator engaged with the second pumping tube segment, responsively to the concentration of the first concentrate and water.Type: GrantFiled: October 26, 2021Date of Patent: May 21, 2024Assignee: NxStage Medical, Inc.Inventors: Goetz Friederichs, William K. Weigel, Dennis M. Treu, Jeffrey H. Burbank, James M. Brugger, Keith David J. Wheeler, Scott W. Newell
-
Patent number: 11975131Abstract: A medical treatment system includes a disposable fluid circuit that includes a water inlet and a batch container arranged to hold a mixture, the mixture including water that is received from the water inlet and at least one concentrate. The fluid circuit also includes a drain line for draining fluid from the disposable fluid circuit, and a manifold with a plurality of fluid lines, the manifold connecting the water inlet, the batch container, a source of the at least one concentrate, and the drain line. A source of purified water supplies the purified water to the water inlet and a sensor detects a property of fluid in the disposable fluid circuit. A controller controls flowing of a first fluid followed by displacement by a second fluid causing the first fluid to flow to the sensor.Type: GrantFiled: December 23, 2020Date of Patent: May 7, 2024Assignee: NxStage Medical, Inc.Inventors: Jeffrey H. Burbank, James M. Brugger, Dennis M. Treu, Mark T. Wyeth
-
Publication number: 20240123128Abstract: A fluid treatment plant has a filter module including at least a first filter and a second filter connected in series and connectable to a supply of fluid. A pump is fluidly connected to the filter module and a controller with a fluid quality sensor is connected to detect a quality of the fluid between the first filter and the second filter. A filter module detector is connected to the controller configured to uniquely detect a filter module connected to the pump, and the controller is controls the pump responsively to a signal from the fluid quality sensor and the module detector. The controller is configured to continue pumping based on output of the quality sensor and/or based on output from the filter module detector.Type: ApplicationFiled: December 27, 2023Publication date: April 18, 2024Applicant: NxStage Medical, Inc.Inventors: Jeffrey H. BURBANK, Dennis M. TREU, Goetz FRIEDERICHS, Brian C. GREEN, Christopher S. MCDOWELL, James M. BRUGGER
-
Publication number: 20240091423Abstract: A method of automatically ensuring against chloramine contamination in purified product water includes supplying input water to the system and purifying the water to generate the purified product water. The purifying includes removing chlorine and chloramine contamination from the water using a carbon filter and supplying chlorine-depleted water to a deionization filter, and deionizing the chlorine-depleted water using said deionization filter. The product water is supplied to a sensor for continuous monitoring of the resistivity of the purified product water by the first sensor, and an alarm is generated indicating possible chloramine breakthrough when the resistivity of the product water falls below a predetermined resistivity level, which is selected to provide a reserve filter capacity before breakthrough would occur. The carbon filter is replaced at least responsively to the alarm to ensure excess capacity of said carbon filter sufficient to prevent chloramine breakthrough in said product water.Type: ApplicationFiled: November 29, 2023Publication date: March 21, 2024Applicant: NxStage Medical, Inc.Inventors: Goetz FRIEDERICHS, Dennis M. TREU, Jeffrey H. BURBANK, Yuriy N. TATASHIN
-
Publication number: 20240082472Abstract: A blood treatment system with pressure sensors may be configured to control blood flow to and from the patient and use readings of the pressure sensors to determine a change in a pressure drop across a flow restriction in the blood circuit to estimate a condition of the machine or the patient, or outputting data responsive to the estimation. Further embodiments employ measurement of pressure drop to detect abnormal viscosity or viscosity variations in order to detect possible infection.Type: ApplicationFiled: November 22, 2023Publication date: March 14, 2024Applicant: NxStage Medical, Inc.Inventors: Mark T. WYETH, Robert Paul MCCARTY, Gregory YANTZ, James Ian JOHNSON, Joseph E. TURK, JR., James M. BRUGGER, Jeffrey H. BURBANK
-
Publication number: 20240075191Abstract: The disclosed subject matter relates to extracorporeal blood processing or other processing of fluids. Volumetric fluid balance, a required element of many such processes, may be achieved with multiple pumps or other proportioning or balancing devices which are to some extent independent of each other. This need may arise in treatments that involve multiple fluids. Safe and secure mechanisms to ensure fluid balance in such systems are described.Type: ApplicationFiled: November 14, 2023Publication date: March 7, 2024Applicant: NxStage Medical, Inc.Inventors: Jeffrey H. BURBANK, Dennis M. TREU, Daniel Joseph RUBERY, JR., Scott W. NEWELL, James M. BRUGGER, William J. SCHNELL, William K. WEIGEL, Steven A. WHITE, Mark T. WYETH, Jerome JAMES, David DESOUZA, Joseph E. TURK, JR., Garrett CASEY
-
Patent number: 11896750Abstract: A fluid treatment plant has a filter module including at least a first filter and a second filter connected in series and connectable to a supply of fluid. A pump is fluidly connected to the filter module and a controller with a fluid quality sensor is connected to detect a quality of the fluid between the first filter and the second filter. A filter module detector is connected to the controller configured to uniquely detect a filter module connected to the pump, and the controller is controls the pump responsively to a signal from the fluid quality sensor and the module detector. The controller is configured to continue pumping based on output of the quality sensor and/or based on output from the filter module detector.Type: GrantFiled: March 25, 2021Date of Patent: February 13, 2024Assignee: NxStage Medical, Inc.Inventors: Jeffrey H. Burbank, Dennis M. Treu, Goetz Friederichs, Brian C. Green, Christopher S. Mcdowell, James M. Brugger
-
Publication number: 20240024553Abstract: A vascular access device may include a blood circuit having an arterial blood line and a venous blood line. The venous blood line is connected to a first access needle and the arterial blood line is connected to a second access needle. The venous blood line is connected to an access component affixed to the second access needle and configured such that when the second access needle is used to infuse blood into a patient, the access component is positioned to withdraw blood and convey it into the venous line. The withdrawn blood may also be conveyed to an air detector to detect withdrawal of the second access needle.Type: ApplicationFiled: October 4, 2023Publication date: January 25, 2024Applicant: NxStage Medical, Inc.Inventors: Joseph E. TURK, JR., Jeffrey H. BURBANK, James M. BRUGGER
-
Patent number: 11865243Abstract: A blood treatment system with pressure sensors may be configured to control blood flow to and from the patient and use readings of the pressure sensors to determine a change in a pressure drop across a flow restriction in the blood circuit to estimate a condition of the machine or the patient, or outputting data responsive to the estimation. Further embodiments employ measurement of pressure drop to detect abnormal viscosity or viscosity variations in order to detect possible infection.Type: GrantFiled: August 30, 2017Date of Patent: January 9, 2024Assignee: NxStage Medical, Inc.Inventors: Mark T. Wyeth, Robert Paul McCarty, Gregory Yantz, James Ian Johnson, Joseph E. Turk, Jr., James M. Brugger, Jeffrey H. Burbank
-
Patent number: 11865240Abstract: A method of automatically ensuring against chloramine contamination in purified product water includes supplying input water to the system and purifying the water to generate the purified product water. The purifying includes removing chlorine and chloramine contamination from the water using a carbon filter and supplying chlorine-depleted water to a deionization filter, and deionizing the chlorine-depleted water using said deionization filter. The product water is supplied to a sensor for continuous monitoring of the resistivity of the purified product water by the first sensor, and an alarm is generated indicating possible chloramine breakthrough when the resistivity of the product water falls below a predetermined resistivity level, which is selected to provide a reserve filter capacity before breakthrough would occur. The carbon filter is replaced at least responsively to the alarm to ensure excess capacity of said carbon filter sufficient to prevent chloramine breakthrough in said product water.Type: GrantFiled: March 2, 2021Date of Patent: January 9, 2024Assignee: NxStage Medical, Inc.Inventors: Goetz Friederichs, Dennis M. Treu, Jeffrey H. Burbank, Yuriy N. Tatashin
-
Patent number: 11850341Abstract: The disclosed subject matter relates to extracorporeal blood processing or other processing of fluids. Volumetric fluid balance, a required element of many such processes, may be achieved with multiple pumps or other proportioning or balancing devices which are to some extent independent of each other. This need may arise in treatments that involve multiple fluids. Safe and secure mechanisms to ensure fluid balance in such systems are described.Type: GrantFiled: August 2, 2022Date of Patent: December 26, 2023Assignee: NxStage Medical, Inc.Inventors: Jeffrey H. Burbank, Dennis M. Treu, Daniel Joseph Rubery, Jr., Scott W. Newell, James M. Brugger, William J. Schnell, William K. Weigel, Steven A. White, Mark T. Wyeth, Jerome James, David Desouza, Joseph E. Turk, Jr., Garrett Casey
-
Patent number: 11813391Abstract: A vascular access device may include a blood circuit having an arterial blood line and a venous blood line. The venous blood line is connected to a first access needle and the arterial blood line is connected to a second access needle. The venous blood line is connected to an access component affixed to the second access needle and configured such that when the second access needle is used to infuse blood into a patient, the access component is positioned to withdraw blood and convey it into the venous line. The withdrawn blood may also be conveyed to an air detector to detect withdrawal of the second access needle.Type: GrantFiled: July 24, 2019Date of Patent: November 14, 2023Assignee: NxStage Medical, Inc.Inventors: Joseph E. Turk, Jr., Jeffrey H. Burbank, James M. Brugger
-
Publication number: 20230338635Abstract: Features for protecting against leaks in a fluid circuit are disclosed. In an embodiment, a first indicator of a leak is used to trigger confirmation by blood flow reversal and air detection in the blood circuit. A method for performing a blood treatment includes, at blood treatment machine, pumping blood to a patient through a first blood line. Further, at a controller of the blood treatment machine, a first signal is received, indicating a probability of a leak in the first blood line. Responsively to the first signal, the controller commands a leak verification operation and receives a second signal indicating whether a leak in the first blood line is verified. Further, a leak indicating signal is generated if the second signal indicates a leak is verified.Type: ApplicationFiled: July 5, 2023Publication date: October 26, 2023Applicant: NxStage Medical, Inc.Inventors: Jeffrey H. Burbank, Dennis M. Treu, James M. Brugger, Daniel Joseph Rubery, JR.
-
Patent number: 11783939Abstract: An automatic monitoring system for a medical treatment device helps to ensure that an a medical treatment device operated at a treatment location away from a clinic is preformed safely. The monitoring system may verify that an assistant is present during treatment of the patient. Among the features disclosed biometric authentication to verify that a trained assistant is present, a presence detector to ensure the assistant is continuously present during treatment, and warning and recovery processes that allow intermittent lapses in the continuous presence of the assistant. The treatment device also communicates with a remote server or terminal.Type: GrantFiled: December 31, 2020Date of Patent: October 10, 2023Assignee: NxStage Medical, Inc.Inventors: Jeffrey H. Burbank, Dennis M. Treu, James M. Brugger
-
Publication number: 20230302209Abstract: A system for filling multiple sterile containers includes a filter with an inlet port and multiple outlet ports, the outlet ports being pre-attached to sterile containers by respective filling lines of each container. Each container has an interior and each of the respective filling lines are connected to a respective container interior. The respective filling lines are sealed to the outlet ports and the containers such that the container interiors are isolated from an external environment except the inlet port, via the filter, forming a combined interior volume which is sterile. A container that is connectable to an outlet port the system has a bladder, a first tube and a second tube connected to the bladder, and a sterilizing filter. The container, the first tube and the second tube, and the sterilizing filter are sterile before water is flowed through the sterilizing filter into the bladder.Type: ApplicationFiled: April 17, 2023Publication date: September 28, 2023Applicant: NxStage Medical, Inc.Inventors: Jeffrey H. Burbank, James M. Brugger
-
Publication number: 20230293794Abstract: A conductivity measurement device includes first and second conductivity measurement flow channels positioned in a fluid circuit and fluidly linked for fluid flow between the first and second conductivity measurement flow channels. A controller having a current source connected to the first and second conductivity channels applies alternating voltages at frequencies that are different, each being respective to one of the first and second conductivity cells.Type: ApplicationFiled: May 23, 2023Publication date: September 21, 2023Applicant: NxStage Medical, Inc.Inventors: Orlando SOTO, Joseph RAUSA, James M. BRUGGER, William J. SCHNELL, Goetz FRIEDERICHS, Jeffrey H. BURBANK, Joseph E. TURK, JR., Scott W. NEWELL, Amanda WOZNIAK